TD-1473 Dose A
0164
Phase 3 small_molecule terminated
Quick answer
TD-1473 Dose A for Ulcerative Colitis (UC) is a Phase 3 program (small_molecule) at Theravance Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Ulcerative Colitis (UC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated